# Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

> **NCT00776347** · NA · COMPLETED · sponsor: **Osaka University** · enrollment: 24 (actual)

## Conditions studied

- Dementia With Lewy Bodies (DLB)

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00776347
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776347, "Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00776347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*